http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107236031-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4732 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107236031-B |
| titleOfInvention | Bioactive polypeptide PMIGVNQELAY, and preparation method and application thereof |
| abstract | The invention relates to the field of protein, in particular to a bioactive polypeptide PMIGVNQELAY, a preparation method and application thereof, wherein the amino acid sequence of the bioactive polypeptide PMIGVNQELAY is Pro-Met-Ile-Gly-Val-Asn-Gln-Glu-Leu-Ala-Tyr. In-vitro antioxidant experiments and in-vitro immune function promotion experiments prove that the polypeptide PMIGVNQELAY has better antioxidant biological activity and immune regulation function, on one hand, the polypeptide has better antioxidant activity, can remove free radicals in a body and improve the quality of life; on the other hand, the bioactive polypeptide PMIGVNQELAY can enhance the in vitro proliferation capacity of lymphocytes and macrophages, promote the phagocytosis of neutral red by the macrophages, improve the resistance of the organism to infection by external pathogens, reduce the morbidity of the organism and have very important significance for developing foods, health-care products and medicines with immunoregulation function and antioxidant function. |
| priorityDate | 2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 415.